Re:The Public Shouldn’t Pay for Drugs Twice
by cdtwigg on Saturday November 05, 2022 @12:53PM
(#33483200)
Yeah it’s the trials that are really expensive, not the basic research. The government gets to spread its dollars around to lots of individual researchers but if they were instead using that money to fund phase III trials (1) we’d have a lot a lot less money for basic research (2) we’d fund a lot fewer phase III trials so (3) we’d see much less drug development overall. Also I’d worry about a potential conflict of interest if the same government is conducting and evaluating the results of drug trials.
Re:The Public Shouldn’t Pay for Drugs Twice
by s1artibartfast on Saturday November 05, 2022 @02:29PM
(#33484221)
Never mind the fact that 17 billion is less than the annual R&D spend at one Pharma company.
I think I'm more interesting comparison would be all national funding for drug R&D versus all corporate R&D funding. This could be done on an annual basis or historic
The claim "By one estimate, the National Institutes of Health spent $17 billion on vaccine technologies fundamental to the Covid-19 vaccine." goes back to the mid-20th Century, is so broad as to be useless and is obviously disqualifying propaganda: https://medicalxpress.com/news/2021-04-covid-vaccine-built-b...